U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07097870) titled 'Predictors of HCC in Post-HCV Cirrhotic Patients After SVR' on July 24.
Brief Summary: This study aims to identify clinical and laboratory factors that predict the occurrence of hepatocellular carcinoma (HCC) in Egyptian cirrhotic patients after achieving a sustained virologic response (SVR) to hepatitis C virus (HCV) treatment. This is a retrospective, two-center, case-control study that will include 132 cases and 264 controls. Variables to be analyzed include demographics, liver disease status, metabolic comorbidities, lifestyle factors, medications, as well as laboratory parameters and non-invasive scoring systems.
Study Start Da...